VMED O2 UK Ltd. - S&P Global Ratings’ Credit Research

VMED O2 UK Ltd.

VMED O2 UK Ltd. - S&P Global Ratings’ Credit Research
VMED O2 UK Ltd.
Published Jan 19, 2022
16 pages (5434 words) — Published Jan 19, 2022
Price US$ 500.00  |  Buy this Report Now

About This Report

  
Abstract:

Overview Key strengths Key risks Broadband network speed advantage compared with very high bit rate digital subscriber line (VDSL). Intense competition, especially at the lower end of the market. Premium positioning and pricing compared with alternative fixed and mobile telecom players, which supports solid profit margins. Increased fiber-to-the-premises investments by BT that will gradually reduce VMED?s competitive advantage. Convergent premium offers that provide scope to increase revenue and reduce customer attrition.Merger cost synergies that could further improve profit margins. Limited cash flow conversion, due to fixed network expansion and expected 5G and fiber to the premises (FTTP) investments.Aggressive financial policy that is likely to limit deleveraging. S&P Global Ratings expects VMED O2 to transition back to revenue growth in 2022,

  
Brief Excerpt:

...VMED O2 has positive medium-term revenue prospects related to market and convergence benefits. S&P Global Ratings expects VMED O2 to transition back to revenue growth in 2022, supported by several factors. These include reduced pressure on the average revenue per user (ARPU) from end-of-contract notifications, since existing customers have already gone through the initial notification and downward repricing process. In addition, we see some recovery in roaming revenue as travel, including for business, gradually resumes. We expect price increases to help offset promotional pricing pressure in the market. We see scope for cross-...

  
Report Type:

Full Report

Issuer
Sector
Global Issuers
Country
Region
Europe, Middle East, Africa
Format:
PDF Adobe Acrobat
Buy Now

VMED O2 UK Ltd. – 2023/02/03 – US$ 500.00

Tear Sheet: VMED O2 UK Ltd. – 2023/12/12 – US$ 500.00

Tear Sheet: VMED O2 UK Ltd. – 2025/04/07 – US$ 500.00

VMED O2 UK Ltd. – 2025/10/13 – US$ 500.00

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "VMED O2 UK Ltd." Jan 19, 2022. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/VMED-O2-UK-Ltd-2782071>
  
APA:
S&P Global Ratings’ Credit Research. (). VMED O2 UK Ltd. Jan 19, 2022. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/VMED-O2-UK-Ltd-2782071>
  
US$ 500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.